Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.

<h4>Background</h4>The complement system is involved in pathogenesis of cardiovascular disease, and might play a role in accelerated atherogenesis in spondylarthropathies (SpA). Hence, we examined complement activation in SpA, and its relationship to antirheumatic treatment, inflammatory...

Full description

Bibliographic Details
Main Authors: Ingrid Hokstad, Gia Deyab, Morten Wang Fagerland, Torstein Lyberg, Gunnbjørg Hjeltnes, Øystein Førre, Stefan Agewall, Tom Eirik Mollnes, Ivana Hollan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0220079

Internet

https://doi.org/10.1371/journal.pone.0220079

Similar Items